Gene therapies that upregulate regenerative components of the extracellular matrix, such as laminins or fibronectins, which are reduced in ALS, may facilitate nerve repair and functional recovery in ALS [215,216,217]. This evidence concerns the gene LAMB2 and amyotrophic lateral sclerosis.